跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 33,201 条关于
“pathological complete response”
全部
33,201
临床试验
18,814
药物
137
机构
47
资讯
14,203
4年前
Nivolumab and Ipilimumab Combination Induces Pathological Complete Response in Advanced Colorectal Cancer
11个月前
Candel Therapeutics Reports Breakthrough Data for CAN-3110 in Recurrent Glioblastoma with Complete Pathological Response
去年
Radiomics Model Predicts Pathological Response to Neoadjuvant Therapy in Hepatocellular Carcinoma
去年
Cadonilimab Plus Chemotherapy Shows Promise in Rectal Cancer Treatment
11个月前
PHERFLOT Trial Achieves 48% Complete Response Rate in HER2-Positive Gastric Cancer
21小时前
MATTERHORN: Durvalumab Plus FLOT Improves Overall Survival in Resectable Gastric and GEJ Adenocarcinoma
9个月前
Chinese-Developed HER2-Targeting ADC TQB2102 Achieves 77% Complete Response Rate in Phase II Breast Cancer Trial
2年前
Perioperative Durvalumab Plus Chemotherapy Significantly Improves Outcomes in Resectable Non-Small Cell Lung Cancer
去年
Intensity Therapeutics and SAKK Initiate Phase 2 Trial of INT230-6 in Triple-Negative Breast Cancer
11个月前
Bispecific Antibody Tobemstomig Shows Promise in Neoadjuvant Melanoma Trial Despite Discontinued Development
第 1 页，共 1421 页
上一页
下一页
